Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
7MAY

WHO upgrades Hondius Andes risk to MODERATE

3 min read
15:24UTC

WHO revised Disease Outbreak News 600 on 9 May, upgrading the ship-level risk for the MV Hondius Andes hantavirus cluster from LOW to MODERATE and confirming all six laboratory-tested cases as Andes virus by PCR and sequencing, with a 38% case-fatality rate across 8 cases and 3 deaths.

ScienceDeveloping
Key takeaway

WHO's MODERATE upgrade on 9 May confirmed Andes virus in all six lab cases, with a 38% case-fatality rate.

WHO revised DON 600 on 9 May, upgrading the ship-level risk for the MV Hondius cluster from LOW to MODERATE and confirming that all six laboratory-tested cases were Andes virus by PCR and full genome sequencing. 1 The revision supersedes the original DON 599 assessment, which logged 7 cases, 3 deaths, and applied standard hantavirus droplet precautions rather than the Andes-specific airborne isolation tier. The Swiss case , confirmed days after DON 599 was published, is the event that forced the upgrade: the Andes strain identification changed both the transmission model and the infection-control calculus.

At the point of revision, the WHO case count stood at 8 cases (6 confirmed, 2 probable) and 3 deaths, producing a 38% case-fatality rate. That CFR is consistent with the baseline for Andes hantavirus in laboratory-confirmed cases, which historically runs 30-40%. The six reporting countries at the time of revision were the Netherlands, South Africa, Switzerland, Germany, the United Kingdom, and Spain. A MODERATE ship-level risk assessment indicates that transmission from the MV Hondius environment to passengers is considered plausible, though person-to-person secondary transmission ashore had not been confirmed.

PAHO's December 2025 Epidemiological Alert had already placed Southern Cone health authorities on notice about rising hantavirus case-fatality figures before the voyage , and the pre-voyage birding expedition traversed Oligoryzomys longicaudatus habitat in Chile, Uruguay, and Argentina, according to WHO's Maria Van Kerkhove, establishing the most plausible rodent-exposure window. 2 The vessel completed disembarkation at Tenerife on 11 May, closing the primary exposure environment. The MODERATE designation remains in force while contact tracing and 45-day incubation monitoring continue across all six countries.

Deep Analysis

In plain English

Most viruses spread through large droplets, which means a surgical mask and keeping your distance from the patient is enough protection for nurses and doctors. A smaller number of viruses spread through tiny airborne particles that can drift across a room, and those require a different kind of mask (called an N95 or FFP3 respirator) and a room designed to stop air flowing outward. **Andes hantavirus** is the only type of hantavirus known to spread between people, so on 8 May the **US Centers for Disease Control** issued guidance requiring hospitals to treat suspected cases as airborne until proved otherwise. The guidance also had a practical message for doctors: a life-support machine called **ECMO** (which does the work of the heart and lungs for a patient) raises survival to about 80% if started early. US patients suspected of having Andes virus are being sent to a specialist hospital in **Nebraska** that has both the ECMO capacity and the bio-containment rooms needed.

What could happen next?
  • Consequence

    Community hospitals receiving suspected Andes cases will need to transfer them to negative-pressure facilities, creating a transfer-delay risk during which nosocomial exposure can occur if precautions are not escalated at the referring hospital.

  • Precedent

    HAN00528 is the first CDC guidance to require airborne precautions for a hantavirus; it will be cited in future guidance for other hantaviruses with potential person-to-person transmission should new evidence emerge.

First Reported In

Update #2 · B3.13 gets better at humans as testing ends

CDC· 12 May 2026
Read original
Causes and effects
This Event
WHO upgrades Hondius Andes risk to MODERATE
The LOW-to-MODERATE upgrade is the first formal threshold crossing since the Swiss Andes confirmation, and it triggers more demanding case-management guidance for the six countries now reporting cases.
Different Perspectives
Chinese health authorities
Chinese health authorities
China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.
US public health authorities
US public health authorities
CIDRAP and Dr Andrew Racine, president of the American Academy of Pediatrics, call 2026's 2,318 confirmed measles cases by 24 July the worst year since 1991's 2,126. Zero deaths against three in 2025 and a 7% hospitalisation rate, down from 11%, show record case counts have not brought record severity.
CEPI
CEPI
CEPI put an rVSV-platform vaccine candidate specific to Bundibugyo ebolavirus into trial-production on 31 July, developed by Hilleman Laboratories with MSD manufacturing and IAVI's reference virus, funded up to $8.5m. Eleven weeks into the third-largest Ebola outbreak on record, this is the first species-matched candidate; the licensed vaccine covers only Zaire ebolavirus.
Médecins Sans Frontières
Médecins Sans Frontières
MSF reports sexual-violence care in Ituri is almost non-existent, with 7 of 14 health centres closed or relocated by fighting, as Panzi Hospital logs 646 new survivors in six months, an 85% rise. Withdrawn US funding for post-exposure prophylaxis has left clinics across three provinces without PEP kits for months, a crisis running alongside Ebola, not caused by it.
DRC health workers at Elikya Ebola Treatment Centre
DRC health workers at Elikya Ebola Treatment Centre
Staff at DRC's Elikya Ebola Treatment Centre walked out on 25 July over unpaid wages, the second such action after Rwampara, while unconfirmed suspects occupy up to 64% of the country's isolation beds awaiting lab results. Workers are absorbing a response that has grown faster than its payroll and its labs.
Uganda's Ministry of Health
Uganda's Ministry of Health
Uganda's ministry says it discharged its last confirmed patient on 16 June, completed every contact's 21-day follow-up, and declared the country Ebola-free on 28 July, exactly 42 days later. It names Hon. Dr Chris Baryomunsi, Minister of Health, as overseeing a 20-case, 2-death outbreak it now considers closed.